Skip to main content

HS Disease

References

  1. North American Clinical Management Guidelines for Hidradenitis Suppurativa: A publication From the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, Intralesional, and Systemic Medical Management. Alikhan A, Sayed C, Alavi A, et al. Journal of the American Academy of Dermatology. 2019;81(1):91-101. doi:10.1016/j.jaad.2019.02.068.
  2. Hidradenitis Suppurativa: Rapid Evidence Review. Wipperman J, Bragg DA, Litzner B. American Family Physician. 2019;100(9):562-569.
  3. Hidradenitis Suppurativa. Sabat R, Alavi A, Wolk K, et al. Lancet (London, England). 2025;405(10476):420-438. doi:10.1016/S0140-6736(24)02475-9.
  4. North American Clinical Management Guidelines for Hidradenitis Suppurativa: A Publication From the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, Evaluation, and the Use of Complementary and Procedural Management. Alikhan A, Sayed C, Alavi A, et al. Journal of the American Academy of Dermatology. 2019;81(1):76-90. doi:10.1016/j.jaad.2019.02.067.
  5. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. Saunte DML, Jemec GBE. JAMA. 2017;318(20):2019-2032. doi:10.1001/jama.2017.16691.
  6. Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management From the Experts. Dagenet CB, Lee KH, Sayed C, Hsiao JL, Shi VY. American Journal of Clinical Dermatology. 2025;26(4):487-497. doi:10.1007/s40257-025-00940-0.
  7. Hidradenitis Suppurativa. Jemec GB. The New England Journal of Medicine. 2012;366(2):158-64. doi:10.1056/NEJMcp1014163.
  8. Insights Into Hidradenitis Suppurativa. van Straalen KR, Prens EP, Gudjonsson JE. The Journal of Allergy and Clinical Immunology. 2022;149(4):1150-1161. doi:10.1016/j.jaci.2022.02.003.
  9. FDA Orange Book. FDA Orange Book.

Articles

  1. Emerging Therapies for Managing Hidradenitis Suppurativa in Patients With Skin of Color_https://www.ajmc.com/view/emerging-therapies-for-managing-hidradenitis-suppurativa-in-patients-with-skin-of-color
  2. FDA Approves Adalimumab-aaty (Yuflyma) Pediatric Indications in Hidradenitis Suppurativa, Uveitis_https://www.hcplive.com/view/fda-approves-adalimumab-aaty-yuflyma-pediatric-indications-in-hidradenitis-suppurativa-uveitis
  3. What is Hidradenitis Suppurativa on Coast Live_https://www.wtkr.com/coast-live/what-is-hidradenitis-suppurativa-on-coast-live#google_vignette
  4. Hidradenitis Suppurativa: Treating the Skin Condition and Its Psychiatric Comorbidities_https://www.dermatologyadvisor.com/features/hidradenitis-suppurativa-treatments-and-comorbidities/
  5. Breakthroughs, Biologics, and Bold Updates in Hidradenitis Suppurativa_https://www.hmpgloballearningnetwork.com/site/derm-app/conference-coverage/breakthrough-biologics-and-bold-updates-hidradenitis-suppurativa

Our Impact This Year

  • People Helped

    1341

  • Volunteer Hours

    3628

  • HS Speaks

    4

  • Rx Supplies

    100 Care Bags

© 2025 ‎International Association of Hidradenitis Suppurativa Network

Powered by Firespring